[Form 4] F&G Annuities & Life, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael J. Nolan, a director of F&G Annuities & Life, Inc. (ticker: FG), received an award of 892 unrestricted shares of common stock on 10/01/2025 in lieu of cash director fees. The transaction was reported on a Form 4 and shows a reported price of $0, reflecting a grant rather than a market purchase. After the grant, the filing reports 50,602 shares beneficially owned directly and 753 shares indirectly through the Michael J. Nolan Trust. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.

Positive

• 892 shares granted in lieu of cash director fees, indicating equity compensation
• Reporting shows 50,602 shares held directly, a disclosed, substantial beneficial stake

Negative

• None.

Insights

Corporate Governance Expert

Director received equity compensation, aligning pay with shareholder interests.

The Form 4 discloses a grant of 892 unrestricted shares to Michael J. Nolan in lieu of cash director fees on 10/01/2025. Equity in place of cash is a standard governance practice to link director incentives to company performance.

The filing shows continued direct ownership of 50,602 shares and 753 shares held indirectly in a trust, which are concrete ownership positions disclosed on the Form 4.

Insider Transactions Analyst

Transaction is a non‑cash grant; no cash outlay or purchase price was reported.

The Form 4 records the transaction price as $0, indicating the shares were issued as compensation rather than bought on the open market. The instrument is unrestricted common stock, per the filing explanation.

The report was executed by an attorney-in-fact and dated 10/03/2025, which completes the disclosure requirement for this director compensation event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Nolan Michael Joseph

(Last) (First) (Middle)

801 GRAND AVENUE

SUITE 2600

(Street)

DES MOINES IA 50309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F&G Annuities & Life, Inc. [ FG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		892	A	$0	50,602	D
Common Stock								753	I	Michael J. Nolan Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of unrestricted common stock in lieu of cash director fees.

	/s/ Tessa Cantonwine, attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FG director Michael J. Nolan receive on 10/01/2025?

He received 892 unrestricted shares of common stock as compensation in lieu of cash director fees.

Was the stock acquisition a market purchase or a grant?

The Form 4 lists a price of $0, indicating the shares were granted, not purchased.

How many FG shares does Michael J. Nolan beneficially own after the grant?

The filing reports 50,602 shares owned directly and 753 shares indirectly via the Michael J. Nolan Trust.

When was the Form 4 signed and filed for this transaction?

The Form 4 shows the signature by attorney-in-fact on 10/03/2025.

What is the nature of the shares received?

The explanation states they are unrestricted common stock granted in lieu of cash director fees.